Mesenchymal Stem Cells in Heterotopic Ossification in Ankylosing Spondylitis: A Bibliometric Study Based on CiteSpace and VOSViewer

References

• van der Heijde D, Ramiro S, Landewé R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):210770. doi:10.1136/annrheumdis-2016-210770
   Web of Science ®Google Scholar
• Ma L, Li Y. Progress of combined diagnosis and treatment of bone loss in ankylosing spondylitis with Chinese and Western medicine. Chin J Osteop. 2017;23(01):029. doi:10.3969/j.issn.1006-7108.2017.01.029
   Google Scholar
• Mielants H, Van den Bosch F. Extra-articular manifestations. Clin Exp Rheumatol. 2009;27(4):S56–61.
   PubMed Web of Science ®Google Scholar
• Dean LE, Jones GT, MacDonald AG, et al. Global prevalence of ankylosing spondylitis. Rheumatology. 2014;53(4):650–657. doi:10.1093/rheumatology/ket387
   PubMed Web of Science ®Google Scholar
• de Winter JJ, van Mens LJ, van der Heijde D, et al. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther. 2016;18(1):196. doi:10.1186/s13075-016-1093-z
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao Y, Xia Q. Advances in the diagnosis and treatment of ankylosing spondylitis. Chin J Orthop. 2015;23(03):235–238. doi:10.3977/j.issn.1005-8478.2015.03.09
   Google Scholar
• Mao Y, Wang M, Wu X. Heterotopic ossification. Chin J Orthop Trauma. 2004;2004:78–82.
   Google Scholar
• Lu X, Liu T, Meng W, Zhu H-L, Xi Y-M, Liu Y-M. Immunomodulatory effects of human bone marrow mesenchymal stem cells on T lymphocytes. J Exp Hematol. 2005;13:651–655. doi:10.3969/j.issn.1009-2137.2005.04.025
   Google Scholar
• Wang CD. Quantitative study of journal authors. Infor Sci. 1998;16(6):471–475.
   Google Scholar
• Meho LI, Yang K. Impact of data sources on citation counts and rankings of LIS faculty: web of science versus Scopus and google scholar. J Am Soc Inf Sci Technol. 2007;58:2105–2125. doi:10.1002/asi.20677
   Web of Science ®Google Scholar
• Tian L, Liang X, Wang Z. Experimental observation on the induction and differentiation of MSC to chondrocytes by non-contact co-culture in vitro. Chin Med Herald. 2008;117(19):16–18. doi:10.3969/j.issn.1673-7210.2008.19.012
   Google Scholar
• Yang J, Liu X, Li Q. Progress of the role of Th17/Treg balance in rheumatoid arthritis. Chin Pharmacol Bull. 2013;29(08):1045–1048. doi:10.3969/j.issn.1001-1978.2013.08.003
   Google Scholar
• Wu Y, Ren M, Yang R, et al. Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis. Arthritis Res Ther. 2011;13(1):R29. doi:10.1186/ar3257
   PubMed Web of Science ®Google Scholar
• Kuca-Warnawin E, Janicka I, Bonek K, et al. Modulatory impact of adipose-derived mesenchymal stem cells of ankylosing spondylitis patients on T helper cell differentiation. Cells. 2021;10(2):280. doi:10.3390/cells10020280
   PubMed Web of Science ®Google Scholar
• Xu F, Guanghao C, Liang Y, et al. Treg-promoted new bone formation through suppressing TH17 by secreting Interleukin-10 in ankylosing spondylitis. Spine. 2019;44(23):E1349–E1355. doi:10.1097/BRS.0000000000003169
   PubMed Web of Science ®Google Scholar
• Huang F. Progress in the treatment of ankylosing spondylitis with TNFα inhibitors. Chin J New Drugs. 2006;853–857. doi:10.3321/j.issn:1003-3734.2006.11.005
   Google Scholar
• Hess K, Ushmorov A, Fiedler J, et al. TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. Bone. 2009;45(2):367–376. doi:10.1016/j.bone.2009.04.252
   PubMed Web of Science ®Google Scholar
• Lories RJ, Luyten FP. Bone morphogenetic protein signaling and arthritis. Cytokine Growth Factor Rev. 2009;20(5–6):467–473. doi:10.1016/j.cytogfr.2009.10.009
   PubMed Web of Science ®Google Scholar
• Briolay A, Lencel P, Bessueille L, et al. Autocrine stimulation of osteoblast activity by Wnt5a in response to TNF-α in human mesenchymal stem cells. Biochem Biophys Res Commun. 2013;430(3):1072–1077. doi:10.1016/j.bbrc.2012.12.036
   PubMed Web of Science ®Google Scholar
• Osta B, Benedetti G, Miossec P. Classical and paradoxical effects of TNF-α on bone homeostasis. Front Immunol. 2014;5:48. doi:10.3389/fimmu.2014.00048
   PubMed Web of Science ®Google Scholar
• Heiland GR, Appel H, Poddubnyy D, et al. High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann Rheum Dis. 2012;71(4):572–574. doi:10.1136/annrheumdis-2011-200216
   PubMed Web of Science ®Google Scholar
• Xie Z, Wang P, Li Y, et al. Imbalance between bone morphogenetic protein 2 and noggin Induces abnormal osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis. Arthritis Rheumatol. 2016;68(2):430–440. doi:10.1002/art.39433
   PubMed Web of Science ®Google Scholar
• Riley EA, Lane JM, Urist MR, et al. Bone morphogenetic protein-2: biology and Application. Clinic Orthop. 1996;324:39. doi:10.1097/00003086-199603000-00006
   PubMedGoogle Scholar
• Riley EH, Lane JM, Urist MR, et al. Bone morphogenetic protein-2: biology and applications. Clin Orthop Relat Res. 1996;324:39–46.
   PubMedGoogle Scholar
• Mo IF, Yip KH, Chan WK, et al. Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors. BMC Cell Biol. 2008;9:52. doi:10.1186/1471-2121-9-52
   PubMedGoogle Scholar
• Li Y, Huang L, Cai Z, et al. A Study of the immunoregulatory function of TLR3 and TLR4 on mesenchymal stem cells in ankylosing spondylitis. Stem Cells Dev. 2019;28(20):1398–1412. doi:10.1089/scd.2019.0039
   PubMed Web of Science ®Google Scholar
• Li YX, Liu T, Liang YW, et al. Integrative analysis of long non-coding RNA and messenger RNA expression in toll-like receptor 4-primed mesenchymal stem cells of ankylosing spondylitis. Ann Transl Med. 2021;9(20):1563. doi:10.21037/atm-21-5020
   PubMed Web of Science ®Google Scholar
• Pöllänen R, Sillat T, Pajarinen J, et al. Microbial antigens mediate HLA-B27 diseases via TLRs. J Autoimmun. 2009;32(3–4):172–177. doi:10.1016/j.jaut.2009.02.010
   PubMed Web of Science ®Google Scholar
• Navid F, Holt V, Colbert RA. The enigmatic role of HLA-B27 in spondyloarthritis pathogenesis. Semin Immunopathol. 2021;43(2):235–243. doi:10.1007/s00281-021-00838-z
   PubMed Web of Science ®Google Scholar
• Liu CH, Raj S, Chen CH, et al. HLA-B27-mediated activation of TNAP phosphatase promotes pathogenic syndesmophyte formation in ankylosing spondylitis.The. J Clin Invest. 2019;129(12):5357–5373. doi:10.1172/JCI125212
   PubMed Web of Science ®Google Scholar